# Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-study-of-bevacizumab-in-patients-with-platinum-resistant-ovarian-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Stephen A. Cannistra,Ursula A. Matulonis,Richard T. Penson,Julie Hambleton,Jakob Dupont,Howard Mackey,Jeffrey A. Douglas,Robert A. Burger,Deborah K. Armstrong,Robert M. Wenham,William P. McGuire |
| Citations | 761 |
| DOI | 10.1200/jco.2007.12.0782 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2096521047 |
| PMID | 18024865 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Robert A. Burger](https://scholariq.org/researchers/robert-a-burger/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Intraperitoneal and Appendiceal Malignancies](https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.